Amundi Trims Stock Holdings in Boston Scientific Co. (NYSE:BSX)
Amundi trimmed its holdings in Boston Scientific Co. (NYSE:BSX – Get Rating) by 7.2% during the fourth quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The firm owned 14,296,846 shares of the medical equipment provider’s stock after selling 1,110,502 shares during the quarter. Amundi owned approximately 1.00% of Boston […]